Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Banco de datos
Tipo del documento
Publication year range
1.
Am J Physiol Endocrinol Metab ; 317(5): E783-E793, 2019 11 01.
Artículo en Inglés | MEDLINE | ID: mdl-31454257

RESUMEN

Perturbations in postnatal leptin signaling have been associated with altered susceptibility to diet-induced obesity (DIO) under high-fat-diet (HFD), albeit with contradicting evidence. Previous studies have shown that alpha murine urokinase-type plasminogen activator (αMUPA) mice have a higher and longer postnatal leptin surge compared with their wild types (WTs) as well as lower body weight and food intake under regular diet (RD). Here we explored αMUPA's propensity for DIO and the effect of attenuating postnatal leptin signaling with leptin antagonist (LA) on energy homeostasis under both RD and HFD. Four-day-old αMUPA pups were treated on alternate days until postnatal day 18 with either vehicle or LA (10 or 20 mg·day-1·kg-1) and weaned into RD or HFD. Compared with RD-fed αMUPA males, HFD-fed αMUPA males showed higher energy intake, even when corrected for body weight difference, and became hyperinsulinemic and obese. Additionally, HFD-fed αMUPA males gained body weight at a higher rate than their WTs mainly because of strain differences in energy expenditure. LA administration did not affect strain differences under RD but attenuated αMUPA's hyperinsulinemia and DIO under HFD, most likely by mediating energy expenditure. Together with our previous findings, these results suggest that αMUPA's leptin surge underlies its higher susceptibility to obesity under HFD, highlighting the role of leptin-related developmental processes in inducing obesity in a postweaning obesogenic environment, at least in αMUPA males. This study therefore supports the use of αMUPA mice for elucidating developmental mechanisms of obesity and the efficacy of early-life manipulations via leptin surge axis in attenuating DIO.


Asunto(s)
Dieta Alta en Grasa , Susceptibilidad a Enfermedades , Leptina/antagonistas & inhibidores , Obesidad/prevención & control , Receptores del Activador de Plasminógeno Tipo Uroquinasa/genética , Animales , Animales Recién Nacidos , Peso Corporal , Ingestión de Alimentos , Metabolismo Energético/efectos de los fármacos , Femenino , Hiperinsulinismo/prevención & control , Ratones , Obesidad/etiología , Embarazo , Transducción de Señal/efectos de los fármacos , Especificidad de la Especie , Aumento de Peso/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda